Evidence map›Paper›PMID 36661299›Full record

ArticleeLife2023

Community composition shapes microbial-specific phenotypes in a cystic fibrosis polymicrobial model system.

Fabrice Jean-Pierre, Thomas H Hampton, Daniel Schultz, Deborah A Hogan, Marie-Christine Groleau, Eric Déziel, George A O'Toole

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
16.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 65 citations in OpenAlex.

  1. InJournal of bacteriology · 2026
    Article
  2. Journal of bacteriology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. InbioRxiv : the preprint server for biology · 2026
    Article
  9. Journal of bacteriology · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. BioMed research international · 2026
    Review
  17. Article
  18. Virulence · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Fabrice Jean-PierreDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, United States.ORCID 0000-0002-3056-8356
Thomas H HamptonDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, United States.
Daniel SchultzDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, United States.
Deborah A HoganDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, United States.
Marie-Christine GroleauCentre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique, Laval, Canada.
Eric DézielCentre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique, Laval, Canada.
George A O'TooleDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, United States.ORCID 0000-0002-2861-4392
Dartmouth College · USInstitut National de la Recherche Scientifique · CA

Funding

Zhao - Proj 2P20GM130454 · NIGMS · DARTMOUTH COLLEGE · PI Chengxiang Qiu · 2019 to 2026
$27.2M
Translational Research CoreP30DK117469 · NIDDK · DARTMOUTH COLLEGE · PI DEAN R MADDEN · 2018 to 2026
$13.9M
Metabolic Basis of Bacterial Community Function in the Cystic Fibrosis AirwayR01AI155424 · NIAID · DARTMOUTH COLLEGE · PI O'TOOLE, GEORGE A. · 2021 to 2025
$2.3M
NIAID NIH HHS R01 AI155424NIDDK NIH HHS P30 DK117469NIGMS NIH HHS P20 GM130454NIH HHS 5 P20 GM130454NIH HHS P30-DK117469NIH HHS R01 AI155424
6 · The paper itself

Abstract

Interspecies interactions can drive the emergence of unexpected microbial phenotypes that are not observed when studying monocultures. The cystic fibrosis (CF) lung consists of a complex environment where microbes, living as polymicrobial biofilm-like communities, are associated with negative clinical outcomes for persons with CF (pwCF). However, the current lack of in vitro models integrating the microbial diversity observed in the CF airway hampers our understanding of why polymicrobial communities are recalcitrant to therapy in this disease. Here, integrating computational approaches informed by clinical data, we built a mixed community of clinical relevance to the CF lung composed of

Indexed as

Cystic FibrosisStaphylococcal InfectionsAnti-Bacterial AgentsBiofilmsHumansPhenotypePseudomonas aeruginosaTobramycinAnti-Bacterial AgentsTobramycinantimicrobial resistanceantimicrobial tolerancecystic fibrosisinfectious diseasemicrobiologyphenazinespolymicrobial interactionsPseudomonas aeruginosa

Identifiers

PMID36661299
PMCPMC9897730
OpenAlexW4317567117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.